Loading…
CSPC 2022 has ended
Navigating Uncertainty; Targeting Sustainability
Back To Schedule
Friday, November 4 • 12:05pm - 12:15pm
ST322: Canada: Medical Isotope Superpower for the Next Generation of Nuclear Medicine / ST322: Canada : une superpuissance en matière d’isotopes médicaux pour la prochaine génération de la médecine nucléaire

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Feedback form is now closed.
Canada: Medical Isotope Superpower for the Next Generation of Nuclear Medicine
Canada : une superpuissance en matière d’isotopes médicaux pour la prochaine génération de la médecine nucléaire

Organized by: TRIUMF Innovations

Canada has historically played a key global leadership role in the development of medical isotopes for the diagnosis and treatment of disease.

There is a new renaissance in nuclear medicine – innovative radiopharmaceuticals are being developed that may provide hope to cancer patients and have failed conventional therapies, and provide new economic development opportunities for Canada that leverage our past investments in cyclotron and reactor infrastructure and expertise. Academia, industry, and government are coming together to strengthen our medical isotope ecosystem and position Canada as a global leader in next generation radiotherapies and radiodiagnostics.
Speakers
avatar for Ms. Kathryn Hayashi

Ms. Kathryn Hayashi

President and CEO - TRIUMF Innovations
Ms. Kathryn Hayashi is President and CEO of TRIUMF Innovations, the business interface and commercialization arm connecting TRIUMF, Canada's particle accelerator centre, to the private sector via industry partnerships, licensing, and company creation. Ms. Hayashi has more than 25... Read More →

Friday November 4, 2022 12:05pm - 12:15pm EDT
Pre-Conference Virtual Zoom Sessions
  Science + Innovation + Economic Development

Attendees (5)